{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:03:01Z","timestamp":1784818981250,"version":"3.55.0"},"reference-count":37,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Extensive-stage small-cell lung cancer (ES-SCLC) treatment has recently been revolutionized by the advent of immune checkpoint inhibitors. This survey was conducted to evaluate the current pattern of care among Italian clinicians, in particular about the integration with radiation therapy (RT). Methods: In June 2023, 225 Italian cancer care professionals were invited to complete a 21-question web-based survey about ES-SCLC management through personal contacts and the Italian Association for Radiotherapy and Clinical Oncology (AIRO) network. Results: We received 90 responses; the majority were radiation oncologists (89%) with more than 10 years of experience (51%). The preferred management of ES-SCLC in patients with a good performance status was concomitant chemo-immunotherapy (84%). Almost all respondents recommended prophylactic cranial irradiation (PCI) (85%), taking into account age and thoracic response; PCI was performed mainly between the end of chemotherapy and before starting immunotherapy (37%), with a three-dimensional conformal technique (46%). Furthermore, 83% of respondents choose to deliver thoracic RT in the case of both an intrathoracic and extrathoracic response, with an RT schedule of 30 Gy\/10 fractions. Stereotactic RT is increasingly being used in oligoprogressions. Conclusions: Our analysis showed the variability of real-world management of ES-SCLC. Future clinical trials and developments are needed to improve the multidisciplinary treatment of these patients.<\/jats:p>","DOI":"10.3390\/curroncol31110501","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:36:39Z","timestamp":1730806599000},"page":"6791-6802","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1068-5958","authenticated-orcid":false,"given":"Alessio","family":"Bruni","sequence":"first","affiliation":[{"name":"Radiation Oncology Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Scotti","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-9022","authenticated-orcid":false,"given":"Maria Alessia","family":"Zerella","sequence":"additional","affiliation":[{"name":"Division of Radiotherapy, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, 20141 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bertolini","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, Modena University Hospital, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Imbrescia","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Olmetto","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-6483","authenticated-orcid":false,"given":"Chiara","family":"Bennati","sequence":"additional","affiliation":[{"name":"Department of Onco-Hematology, AUSL della Romagna, 48121 Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-9511","authenticated-orcid":false,"given":"Francesco","family":"Cuccia","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, ARNAS Civico Hospital, 90145 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Miele","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[{"name":"Advanced Radiation Oncology Department, Cancer Care Center, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-8465","authenticated-orcid":false,"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"},{"name":"Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ciammella","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Azienda USL-Istituto di Ricovero e Cura a Carattere Scientifico Di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-7069","authenticated-orcid":false,"given":"Stefano","family":"Vagge","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, E.O. Ospedali Galliera, 16128 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Galaverni","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-6779","authenticated-orcid":false,"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Department of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Badellino","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Department of Oncology, University of Turin, 10125 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-8925","authenticated-orcid":false,"given":"Ruggero","family":"Spoto","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiosurgery, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6196-5864","authenticated-orcid":false,"given":"Emanuele","family":"Al\u00ec","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Azienda USL-Istituto di Ricovero e Cura a Carattere Scientifico Di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department, ASST Spedali Civili and University of Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.20.03364","article-title":"Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline","volume":"39","author":"Daly","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Nicholson","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.23.01435","article-title":"Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline","volume":"41","author":"Khurshid","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1634\/theoncologist.12-9-1096","article-title":"Small cell lung cancer: Have we made any progress over the last 25 years?","volume":"12","author":"Lally","year":"2007","journal-title":"Oncologist"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.21037\/tlcr-20-305","article-title":"Thoracic radiotherapy in small cell lung cancer-a narrative review","volume":"10","author":"Levy","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): Updated results from a randomised, controlled, open-label, phase 3 trial","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100408","DOI":"10.1016\/j.esmoop.2022.100408","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN","volume":"7","author":"Chen","year":"2022","journal-title":"ESMO Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated Overall Survival and PD-L1 Subgroup Analysis of Patients with Extensive-Stage Small-Cell Lung Cancer Treated with Atezolizumab, Carboplatin, and Etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107166","DOI":"10.1016\/j.lungcan.2023.03.002","article-title":"Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations","volume":"179","author":"Sun","year":"2023","journal-title":"Lung Cancer"},{"key":"ref_12","unstructured":"(2024, September 01). Chemo-Immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-Cell Lung Cancer (TRIPLEX), Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05223647."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bozorgmehr, F., Christopoulos, P., Chung, I., Cvetkovic, J., Fei\u00dft, M., Krisam, J., Schneider, M.A., Heu\u00dfel, C.P., Kreuter, M., and M\u00fcller, D.W. (2022). Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease\u2014A randomized, open-label, multicenter phase II trial. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10074-9"},{"key":"ref_14","unstructured":"(2024, September 01). NIH, Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04402788."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: A multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11547-018-0868-5","article-title":"Radiation therapy in small cell lung cancer: A national Italian survey","volume":"123","author":"Ciammella","year":"2018","journal-title":"Radiol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1002\/cncr.34966","article-title":"Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status","volume":"129","author":"Agarwal","year":"2023","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cllc.2023.05.005","article-title":"Chemoimmunotherapy as the First-Line Treatment for Patients with Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3","volume":"24","author":"Agarwal","year":"2023","journal-title":"Clin. Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/1759-7714.14712","article-title":"Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decade","volume":"13","author":"Longo","year":"2022","journal-title":"Thorac. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","article-title":"Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: Pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214","volume":"86","author":"Gondi","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Higgins, K.A., Curran WJJr Liu, S.V., Yu, W., Brockman, M., Johnson, A., Bara, I., and Bradley, J.D. (2020). Patterns of Disease Progression after Carboplatin\/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC). Int. J. Radiat. Oncol. Biol. Phys., 108.","DOI":"10.1016\/j.ijrobp.2020.09.020"},{"key":"ref_23","first-page":"100330","article-title":"Impact of Brain Metastases on Treatment Patterns and Outcomes with First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report","volume":"3","author":"Chen","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cllc.2023.08.009","article-title":"The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series","volume":"24","author":"Gross","year":"2023","journal-title":"Clin. Lung Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cllc.2016.09.007","article-title":"Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer","volume":"18","author":"Zhao","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"ref_26","unstructured":"(2024, September 01). S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients with Small Cell Lung Cancer, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04155034."},{"key":"ref_27","unstructured":"(2024, September 01). PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-Cell Lung Cancer Patients (PRIMALung Study) (PRIMALung), Available online: https:\/\/clinicaltrials.gov\/study\/NCT04790253."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Expert Panel Thoracic Malignancies, Higgins, K.A., Simone, C.B., Amini, A., Chetty, I.J., Donington, J., Edelman, M.J., Chun, S.G., Kestin, L.L., and Movsas, B. (2021). American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC. J. Thorac. Oncol., 16, 54\u201365.","DOI":"10.1016\/j.jtho.2020.09.013"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Electronic address: Clinicalguidelines@esmo.org. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jtho.2017.06.015","article-title":"Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937","volume":"12","author":"Gore","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: A phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cozzi, S., Bruni, A., Ruggieri, M.P., Borghetti, P., Scotti, V., Franceschini, D., Fiore, M., Taraborrelli, M., Salvi, F., and Galaverni, M. (2023). Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study. Cancers, 15.","DOI":"10.3390\/cancers15020434"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S1067","DOI":"10.1016\/j.annonc.2023.09.1231","article-title":"2000P Efficacy and safety of thoracic radiotherapy after first-line immunotherapy in extensive stage small cell lung cancer: A multi-center retrospective study","volume":"34","author":"Wu","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S1060","DOI":"10.1016\/j.annonc.2023.09.1219","article-title":"1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data","volume":"34","author":"Bozorgmehr","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cllc.2021.07.003","article-title":"Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases","volume":"23","author":"Gjyshi","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cllc.2023.11.005","article-title":"Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort","volume":"25","author":"Borghetti","year":"2024","journal-title":"Clin. Lung Cancer"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/501\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:32Z","timestamp":1760113592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["curroncol31110501"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31110501","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}